• Re: Many more delta variant deaths.

    From Leroy N. Soetoro@21:1/5 to All on Wed Oct 20 13:06:52 2021
    XPost: alt.fan.rush-limbaugh, alt.atheism, alt.religion.christian.roman-catholic
    XPost: alt.politics, alt.politics.trump, alt.politics.republicans
    XPost: alt.politics.democrats, alt.abortion, alt.religion.christian.roman-catholic
    XPost: soc.women

    That Jewboy Alex Jones found a scientist who says it's a big hoax and that
    all the other ones are in on the BIG CONSPIRACEEEE!

    "MIT Scientist Exposes Covid-19 Hoax in Bombshell Interview - MUST SEE!
    Dr. Andrew Kaufman joins The Alex Jones Show to break down the fear- programming used on the masses to get them to submit to medical tyranny.
    Alex Jones breaks down the shocking admission by a COVID vaccine program director David LV Bauer explaining how the Pfizer injection brainwashes
    you into hating Trump and not sending him money".




    a322x1n wrote

    <https://www.archyde.com/the-delta-variant-has-a-137-higher-risk-of-
    death


    <https://tinyurl.com/yrh94ydj>

    the Delta variant has a 137% higher risk of death
    July 24, 2021 by archyde
    The World Health Organization (WHO) confirmed a greater danger of the
    Delta variant of the coronavirus than increases the risk of death by
    137.

    The data are based on studies conducted in Canada and China that have
    not been published in scientific journals at this time.

    According to the Canadian study, the health risks of contracting
    COVID-19 with the Delta variant, the danger of having to go to the
    hospital increases by around 120 percent, and that of needing intensive
    care is around 287 percent, so the risk of death rises to 137 percent.

    For the China study, people who were quarantined after contact with
    someone infected with the Delta variant were examined, those who were
    tested positive for the PCR test after an average of four days, instead
    of six, as was the case with the first variants.

    Likewise, the viral load was found to be 1,200 times higher in the first positive test than in the original variants of the virus.

    The result of those works “It suggests that this worrying variant may reproduce more quickly and be more contagious in the early stages of infection.”, reported the WHO.

    The organization also pointed out that the Delta variant already
    accounts for more than three-quarters of new COVID cases in many
    countries and will predominate in the coming months.

    “It (the Delta variant) is expected to quickly supplant the other
    variants and become the dominant lineage in circulation in the coming months“said the UN agency.

    The Delta variant, which was first detected in India and now has a
    presence in 124 countries and territories, 13 more than last week,
    compared to 180 (six more) for the Alpha variant, which was detected in
    the United Kingdom. , the 130 (seven more) of the Beta, which was
    identified for the first time in South Africa, and the 78 (three more)
    of the Gamma, which appeared in Brazil.
    .
    Global alarm: Delta variant has 137% higher risk of death.

    Why is the Delta variant so contagious?
    With the aim of answering this question, a group of Chinese researchers
    from the local Centers for Disease Control and Prevention in Guandong
    set the goal of knowing the spread and infection times of the Delta
    variant.

    The results, which were published in the journal Virological, indicate
    that the incubation and subsequent positive patient indicator after the
    PCR sample is at least two days less than the original strain of
    SARS-CoV-2.

    In this way, the amount of time the virus needed to replicate at high
    enough levels as to be detectable it was 5.61 days for the original
    virus and 3.71 days for the Delta variant.

    John Connor, a researcher at the National Laboratories for Emerging Infectious Diseases at Boston University, told LiveScience that this indicates that the contagion window is much smaller, which increases the spread more quickly.

    “As we know, individuals experience a latent period after infection,
    during which viral titers (concentrations) are too low to be detected.
    As viral proliferation continues within the host, the viral load will eventually reach a detectable level. and it will become infectious.
    Knowing when an infected person can spread viruses is essential to
    design intervention strategies to break the chains of transmission,
    “said the expert.

    The Chinese researchers found that the viral loads in the delta variant infections were 1,260 times higher than those of the original virus infections. This suggests that the Delta variant can replicate in the
    body at a faster rate than the parent virus.

    Research data from Canada has shown that one dose of the Covid-19
    vaccine from AstraZeneca and the University of Oxford is 82 percent
    effective against hospitalization or death caused by Beta / Gamma
    variants of the virus. SARS-CoV-2, as well as 87 percent versus Delta
    and 90 percent versus Alpha.

    Based on these results, the vaccine was effective against milder
    symptomatic disease although, as data were only reported after a first
    dose rather than the indicated two-dose schedule, where efficacy is
    known to be higher in this setting of disease, the efficacy was lower
    than against severe disease. The efficacy of the vaccine against any
    disease.

    A phase I / II trial carried out by the University of Oxford and the University of the Witwatersrand in January had shown limited efficacy
    against mild disease mainly due to the Beta variant. It was unable to adequately determine the efficacy of the vaccine against severe illness, including hospitalization and death, as the subjects were predominantly healthy young adults who only experienced mild illness.

    “With different variants that threaten to disrupt our exit route from
    the pandemic, this real-world evidence shows that our vaccine provides a
    high level of protection against the most severe forms of the disease,
    even after a single injection. It is essential that Let’s continue to
    protect as many people as possible in every corner of the world to stay
    ahead of this deadly virus, “AstraZeneca Executive Vice President of Biopharmaceutical R&D, Mene Pangalos, told Infosalus.

    The analysis included 69,533 individuals who tested positive for
    SARS-CoV-2 during December 2020 to May 2021 in Ontario, Canada; with
    28,705 (6.8 percent) positive for non-worrisome variants of SARS-CoV-2
    and 40,828 (9.7 percent) positive for a worrying variant.


    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)
  • From Leroy N. Soetoro@21:1/5 to All on Thu Nov 11 19:02:32 2021
    XPost: alt.fan.rush-limbaugh, alt.atheism, alt.religion.christian.roman-catholic
    XPost: alt.politics, alt.politics.trump, alt.politics.republicans
    XPost: alt.politics.democrats, alt.abortion, alt.religion.christian.roman-catholic
    XPost: soc.women

    That Jewboy Alex Jones found a scientist who says it's a big hoax and that
    all the other ones are in on the BIG CONSPIRACEEEE!

    "MIT Scientist Exposes Covid-19 Hoax in Bombshell Interview - MUST SEE!
    Dr. Andrew Kaufman joins The Alex Jones Show to break down the fear- programming used on the masses to get them to submit to medical tyranny.
    Alex Jones breaks down the shocking admission by a COVID vaccine program director David LV Bauer explaining how the Pfizer injection brainwashes
    you into hating Trump and not sending him money".




    a322x1n wrote

    <https://www.archyde.com/the-delta-variant-has-a-137-higher-risk-of-
    death


    <https://tinyurl.com/yrh94ydj>

    the Delta variant has a 137% higher risk of death
    July 24, 2021 by archyde
    The World Health Organization (WHO) confirmed a greater danger of the
    Delta variant of the coronavirus than increases the risk of death by
    137.

    The data are based on studies conducted in Canada and China that have
    not been published in scientific journals at this time.

    According to the Canadian study, the health risks of contracting
    COVID-19 with the Delta variant, the danger of having to go to the
    hospital increases by around 120 percent, and that of needing intensive
    care is around 287 percent, so the risk of death rises to 137 percent.

    For the China study, people who were quarantined after contact with
    someone infected with the Delta variant were examined, those who were
    tested positive for the PCR test after an average of four days, instead
    of six, as was the case with the first variants.

    Likewise, the viral load was found to be 1,200 times higher in the first positive test than in the original variants of the virus.

    The result of those works “It suggests that this worrying variant may reproduce more quickly and be more contagious in the early stages of infection.”, reported the WHO.

    The organization also pointed out that the Delta variant already
    accounts for more than three-quarters of new COVID cases in many
    countries and will predominate in the coming months.

    “It (the Delta variant) is expected to quickly supplant the other
    variants and become the dominant lineage in circulation in the coming months“said the UN agency.

    The Delta variant, which was first detected in India and now has a
    presence in 124 countries and territories, 13 more than last week,
    compared to 180 (six more) for the Alpha variant, which was detected in
    the United Kingdom. , the 130 (seven more) of the Beta, which was
    identified for the first time in South Africa, and the 78 (three more)
    of the Gamma, which appeared in Brazil.
    .
    Global alarm: Delta variant has 137% higher risk of death.

    Why is the Delta variant so contagious?
    With the aim of answering this question, a group of Chinese researchers
    from the local Centers for Disease Control and Prevention in Guandong
    set the goal of knowing the spread and infection times of the Delta
    variant.

    The results, which were published in the journal Virological, indicate
    that the incubation and subsequent positive patient indicator after the
    PCR sample is at least two days less than the original strain of
    SARS-CoV-2.

    In this way, the amount of time the virus needed to replicate at high
    enough levels as to be detectable it was 5.61 days for the original
    virus and 3.71 days for the Delta variant.

    John Connor, a researcher at the National Laboratories for Emerging Infectious Diseases at Boston University, told LiveScience that this indicates that the contagion window is much smaller, which increases the spread more quickly.

    “As we know, individuals experience a latent period after infection,
    during which viral titers (concentrations) are too low to be detected.
    As viral proliferation continues within the host, the viral load will eventually reach a detectable level. and it will become infectious.
    Knowing when an infected person can spread viruses is essential to
    design intervention strategies to break the chains of transmission,
    “said the expert.

    The Chinese researchers found that the viral loads in the delta variant infections were 1,260 times higher than those of the original virus infections. This suggests that the Delta variant can replicate in the
    body at a faster rate than the parent virus.

    Research data from Canada has shown that one dose of the Covid-19
    vaccine from AstraZeneca and the University of Oxford is 82 percent
    effective against hospitalization or death caused by Beta / Gamma
    variants of the virus. SARS-CoV-2, as well as 87 percent versus Delta
    and 90 percent versus Alpha.

    Based on these results, the vaccine was effective against milder
    symptomatic disease although, as data were only reported after a first
    dose rather than the indicated two-dose schedule, where efficacy is
    known to be higher in this setting of disease, the efficacy was lower
    than against severe disease. The efficacy of the vaccine against any
    disease.

    A phase I / II trial carried out by the University of Oxford and the University of the Witwatersrand in January had shown limited efficacy
    against mild disease mainly due to the Beta variant. It was unable to adequately determine the efficacy of the vaccine against severe illness, including hospitalization and death, as the subjects were predominantly healthy young adults who only experienced mild illness.

    “With different variants that threaten to disrupt our exit route from
    the pandemic, this real-world evidence shows that our vaccine provides a
    high level of protection against the most severe forms of the disease,
    even after a single injection. It is essential that Let’s continue to
    protect as many people as possible in every corner of the world to stay
    ahead of this deadly virus, “AstraZeneca Executive Vice President of Biopharmaceutical R&D, Mene Pangalos, told Infosalus.

    The analysis included 69,533 individuals who tested positive for
    SARS-CoV-2 during December 2020 to May 2021 in Ontario, Canada; with
    28,705 (6.8 percent) positive for non-worrisome variants of SARS-CoV-2
    and 40,828 (9.7 percent) positive for a worrying variant.


    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)